ZD0473 pharmacokinetics in Japanese patients: a Phase I dose-escalation study
- 1 December 2002
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 38, S1-S5
- https://doi.org/10.1016/s0959-8049(02)80012-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Open-label phase II study of ZD0473 in patients with metastatic hormone-refractory prostate cancerEuropean Urology Supplements, 2002
- A Validated Liquid Chromatography/Tandem Mass Spectrometry Assay forcis-Amminedichloro(2-methylpyridine)platinum(II) in Human Plasma UltrafiltrateAnalytical Chemistry, 2002
- Pharmacokinetic (PK)/pharmacodynamic (PD) trial of the new generation platinum compound ZD0473 administered as an iv infusion every 21 daysEuropean Journal Of Cancer, 2001
- ZD0473 phase II monotherapy trial in second-line non-small cell lung cancerEuropean Journal Of Cancer, 2001
- A phase II trial of zd0473 in patients with metastatic breast cancer. A National Cancer Institute of Canada clinical trials group study (NCIC CTG-IND 129)European Journal Of Cancer, 2001
- Activity of ZD0473 in small-cell lung cancer: an update in patients relapsing after one prior chemotherapy regimenEuropean Journal Of Cancer, 2001
- Preclinical and clinical overview of the novel platinum complex, ZD0473 (cis-amminedichloro[2-methylpyridine] platinum[II])Lung Cancer, 2000
- Clinical Pharmacokinetics and Administration of Established Platinum DrugsDrugs, 2000
- AMD473Drugs of the Future, 1998
- Clinical Pharmacokinetics and Dose Optimisation of CarboplatinClinical Pharmacokinetics, 1997